Nanomagnetic gene transfection for non-viral gene delivery in nih 3t3 mouse embryonic fibroblasts

Materials

Volumn 6, Issue 1, 2013, Pages 255-264

  Fouriki, Angeliki ^a   Dobson, Jon ^a,b,c  

^a KEELE UNIVERSITY   (United Kingdom)

^b University of Florida   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

DNA; Magnetic field; Magnetic nanoparticles; Nanomagnetic gene transfection; Non viral gene transfection

Indexed keywords

GENE TRANSFECTION; GREEN FLUORESCENT PROTEIN; MAGNETIC NANO-PARTICLES; MAGNETIC NANOPARTI CLES (MNPS); MOUSE EMBRYONIC FIBROBLASTS; NON-VIRAL GENE DELIVERY; NON-VIRAL TRANSFECTIONS; TRANSFECTION EFFICIENCY;

CELL CULTURE; DNA; EFFICIENCY; FIBROBLASTS; GENE TRANSFER; GENES; LIPOSOMES; MAGNETIC FIELDS; MAMMALS; NANOMAGNETICS; NANOPARTICLES; NANOSYSTEMS;

MOLECULAR BIOLOGY;

EID: 84875801716     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma6010255     Document Type: Article

References (27)

1. Cho, H.J.; Lee, T.S.; Park, J.B.; Park, K.K.; Choe, J.Y.; Sin, D.I.; Park, Y.Y.; Moon, Y.S.; Lee, K.G.; Yeo, J.H.; et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J. Biochem. Mol. Biol. 2007, 40, 1069-1076.
2. Kersting, C.; Gebert, C.; Agelopoulos, K.; Schmidt, H.; van Diest, P.J.; Juergens, H.; Winkelmann, W.; Kevric, M.; Gosheger, G.; Brandt, B.; et al. Epidermal growth factor receptor expression in high-grade osteosarcoma is associated with a good clinical outcome. Clin. Cancer Res. 2007, 13, 2998-3005.
3. Lamoureux, F.; Richard, P.; Wittrant, Y.; Battaglia, S.; Pilet, P.; Trichet, V.; Blanchard, F.; Gouin, F.; Pitard, B.; Heymann, D.; Redini, F. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: Blockage of the vicious cycle between tumor cell proliferation and bone resorption, Cancer Res. 2007, 67, 7308-7318.
4. Lu, Y. Viral based gene therapy for prostate cancer. Curr. Gene Ther. 2001, 1, 183-200.
5. Bhattarai, S.R.; Kim, S.Y.; Jang, K.Y.; Lee, K.C.; Yi, H.K.; Lee, D.Y.; Kim, H.Y.; Hwang, P.H. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J. Virol. Methods 2008, 147, 213-218.
6. Verma, I.M. A tumultuous year for gene therapy. Mol. Ther. 2000, 2, 415-416.
7. Spack, E.G.; Corgi, F.L. Developing non-viral DNA delivery systems for cancer and infectious disease. Drug Discov. Today 2001, 6, 186-197.
8. Mintzer, M.A.; Simanek, E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109, 259-302.
9. Wobus, A.M.; Boheler, K.R. Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol. Rev. 2005, 85, 635-678.
10. Levenberg, S.; Rouwkema, J.; Macdonald, M.; Garfein, E.S.; Kohane, D.S.; Darland, D.C.; Marini, R.; van Blitterswijk, C.A.; Mulligan, R.C.; D'more, P.A.; Langer, R. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 2005, 23, 879-884.
11. Sarasam, A.; Madihally, S.V. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials 2005, 26, 5500-5508.
12. Mah, C.; Zolotukhin, I.; Fraites, T.J.; Dobson, J.; Batich, C.; Byrne, B.J. Microsphere-mediated delivery of recombinant AVV vectors in vitro and in vivo. Mol. Ther. 2000, 1, S239-S242.
13. Mah, C.; Fraites, T.J.; Zolotukhin, I.; Song, S.H.; Flotte, T.R.; Dobson, J.; Batich, C.; Byrne, B.J. Improved method of recombinant AAV2 delivery for systemic targeted gene delivery. Mol. Ther. 2002, 6, 106-112.
14. Scherer, F.; Anton, M.; Schillinger, U.; Henke, J.; Bergemann, C.; Krüger, A.; Gänsbacher, B.; Plank, C. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002, 9, 102-109.
15. Plank, C.; Schillinger, U.; Scherer, F.; Bergemann, C.; Remy, J.S.; Krotz, F.; Anton, M.; Lausier, J.; Rosenecker, J. The magnetofection method: Using magnetic force to enhance gene delivery. Biol. Chem. 2003, 384, 737-747.
16. Krotz, F.; Sohn, H.Y.; Gloe, T.; Plank, C.; Pohl, U. Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vasc. Res. 2003, 40, 425-434.
17. Dobson, J. Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther. 2006, 13, 283-287.
18. McBain, S.C.; Griesenbach, U.; Xenariou, S.; Keramane, A.; Batich, C.D.; Alton, E.W.F.W.; Dobson, J. Magnetic nanoparticles as gene delivery agents: Enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 2008, 19, 405102:1-405102:5.
19. Pickard, M.; Chari, D. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by "magnetofection": Effects of static and oscillating fields. Nanomedicine 2010, 5, 217-232.
20. Fouriki, A.; Clements, M.A.; Farrow, N.; Dobson, J. Efficient transfection of MG-63 osteoblasts using magnetic nanoparticles and oscillating magnetic fields. J. Tissue Eng. Regen. Med. 2012, doi:10.1002/term.1508.
21. Zhang, Y.; Kohler, N.; Zhang, M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23, 1553-1561.
22. Dobson, J. Magnetic micro and nano particle based targeting for drug and gene delivery. Nanomedicine 2006, 1, 31-37.
23. Kim, S.J.; Yoon, T.J.; Yu, K.N.; Kim, B.G.; Park, S.J.; Kim, H.W.; Lee, K.H.; Park, S.B.; Lee, J.; Cho, M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89, 338-347.
24. McBain, S.C.; Yiu, H.H.P.; Dobson, J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 2008, 3, 169-180.
25. Dobson, J.; Batich, C.D. Gene delivery. Eur. Pat. Appl. WO2006111770, 22 April 2005.
26. Fouriki, A.; Farrow, N.; Clements, M.; Dobson, J. Evaluation of the magnetic field requirements for nanomagnetic gene transfection. Nano Rev. 2010, 1, 5167, doi:10.3402/nano.v1i0.5167.
27. Lim, J.; Dobson, J. Delivery of short interfering ribonucleic acid-complexed magnetic nanoparticles in an oscillating field occurs via caveolae-mediated endocytosis. PLoS One 2012, 7, e51350, doi:10.1371/journal.pone.0051350.